ERBB2 and neoplasm: In these, and in subsequent studies, it has been shown that the basal-like group is enriched for tumours that lack expression of hormone receptors and of HER2 and has a more aggressive clinical behaviour, a distinctive metastatic pattern [4, 5] and a poor prognosis despite responding to conventional neoadjuvant and adjuvant chemotherapy regimens[6, 7].